Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2007

View Archived Issues

Increased immunogenicity of two novel malaria vaccine candidates in preclinical studies

Recent patents cover new therapeutic agents for cancer

Recent NeuroSearch patents disclose new antipsychotic agents

Shire reviews Q1 developments

Studies detail activity of ranibizumab in macular degeneration

Targeting the sodium pump subunits with topical siRNA may be used in treating ocular hypertension

VEGF Trap improves diabetic macular edema

AVI receives three bioterrorism contracts from DoD

Abraxis BioScience and Cenomed establish CNS joint venture

BIIB-014 begins phase II for Parkinson's disease

VASTox selects preclinical candidate for Duchenne muscular dystrophy

Bepotastine shows promise in allergic conjunctivitis

Long-term remissions of ocular Behcet's disease with interferon therapy

Novel preclinical data on immunosuppression presented at the American Transplant Congress

Approvable letter for Provenge

CellCyte signs production agreement for CCG-TH30

Second cohort completes Amorcyte's phase I cardiac cell therapy study

GMX-1777 begins phase I study in refractory solid tumors and lymphomas

Invitrogen and Cytori partner to offer adipose stem cell research products

Phase I trials begin for Oramed Insulin capsules

Bristol-Myers Squibb and Isis collaborate on antisense drugs targeting PCSK9

P&G terminates Hedgehog agonist hair growth collaboration with Curis

FDA Advisory Committee votes against Junovan

Meda acquires European rights to omeprazole/ketaprofen combination product

Panflu cleared for phase II testing in China

Favorable release profile of extended-release morphine sulfate plus sequestered naltrexone

FDA approves Neupro for early Parkinson's disease

Taiho files for Japanese approval for Zosyn

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...